Saturday, 31 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Board Meeting Date

Fredun Pharmaceuticals Board Meeting Date

Fredun Pharmaceuticals Ltd has scheduled a board meeting on August 5, 2026, to consider and approve its unaudited financial results for the quarter ended June 30, 2026.

Source

BSE filing, NSE: FREDUN. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Fredun Pharmaceuticals Ltd: key numbers

Share price
₹1,366.05
Market cap
₹1,957 Cr
Revenue (annual)
₹635.5 Cr
Net profit (annual)
₹32.62 Cr
P/E (TTM)
44.7×Sector 45.9×
Promoter holding
43.62%-0.95% QoQ
FII holding
0.69%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Fredun Pharmaceuticals Ltd

All →
18:26 IST BSE
Convertible Warrants

Fredun Pharmaceuticals Convertible Warrants

Fredun Pharmaceuticals allotted 44,000 equity shares to three non-promoter investors on conversion of 14,667 warrants. The conversion follows the 1:2 bonus issue, which adjusted warrant entitlements.

Other board meeting date announcements

All →